Tidligere styreleder i Oslo Cancer Cluster og påtroppende leder av Oslo Cancer Cluster Incubator. Starter 1. januar 2015.

Joined September 2014
Rudi Giuliani 1987 - “If we can teach our entire society that no matter how powerful you are … you have to pay a price when you violate the law” - 2023 what happened to this guy?
1
60
AMR is a huge global problem. Globalisation, climate change and wars cause migration and spread of multiresistant bacteria to Norway. EU has recently asked its Member states to step up support for innovation of new drugs. #amr lnkd.in/dGnFHcGk
35
Det er på tide å ta dette alvorlig. Vi trenger et norsk fond som kan støtte de dyre kliniske forskningsprogrammene slik at ny teknologi når pasientene svd.se/a/l3adWo/skrammande-b…
37
It was a great first half of 2023 for Adjutec. We're preparing for a first-in-man study and see appetite from international pharma for our antibiotic technology. Stay tuned and have a good Summer! lnkd.in/dyNH7EFx OCC #pharma lnkd.in/dUh5EchB
1
24
Bjørn Klem retweeted
Dette er sååååå fortjent! Gratulerer til Gustav Gaudernack!
This Post is from an account that no longer exists. Learn more
3
10
783
Adjutec avsluttet stor antibiotika kongress i København med 3 postere som viste potensialet i vår teknologi. Nå planlegger vi å starte klinikk mot slutten av året! @OsloCancer @AdjutecPharma @ECCMID
1
10
496
The entire Adjutec team attends the ECCMID antibiotic conference in Copenhagen this Saturday to Tuesday. Use the opportunity to touch base and discuss. @AdjutecPharma
2
9
362
Beredskap er vanskelig, enten det er pandemier eller bankkrise... nytimes.com/2023/03/19/opini… nytimes.com/2023/03/19/opini…
18
Adjutec tar sitt antibiotika produkt til fase 1 klinikk. Beskjeden fra kongressen i Basel er at det medisinske behovet er større enn noen sinne. Vi står på videre.
1
76
Adjutec was granted NOK 2mill from Oslo count today for optimsation of the synthesis of our lead antibiotic compounds. Strong recognision of our dedicated R@D team! #amr #occ
2
4
237
Adjutec is raising capital for taking our lead antibiotic product to phase 1 in 2023. An important product for global healthcare. amr# adjutec# lnkd.in/dJCeRnXz
1
2